David L. Earnshaw

1.2k total citations
21 papers, 849 citations indexed

About

David L. Earnshaw is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, David L. Earnshaw has authored 21 papers receiving a total of 849 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Epidemiology and 3 papers in Oncology. Recurrent topics in David L. Earnshaw's work include RNA and protein synthesis mechanisms (4 papers), Herpesvirus Infections and Treatments (3 papers) and Glycosylation and Glycoproteins Research (2 papers). David L. Earnshaw is often cited by papers focused on RNA and protein synthesis mechanisms (4 papers), Herpesvirus Infections and Treatments (3 papers) and Glycosylation and Glycoproteins Research (2 papers). David L. Earnshaw collaborates with scholars based in United Kingdom, United States and Poland. David L. Earnshaw's co-authors include R. Anthony Vere Hodge, K. Edmonds, Robert M. Perkins, T. H. Bacon, Andrew J. Pope, Jeremy W. Dale, G. Gordon Gibson, Brian G. Lake, Tony Bradshaw and Rajesh K. Sharma and has published in prestigious journals such as Nucleic Acids Research, Biochemical Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

David L. Earnshaw

21 papers receiving 804 citations

Peers

David L. Earnshaw
Deborah C. Melder United States
Hongwei Yao China
Nevena Veljković Serbia
Tamar Bino Israel
J D Karkas United States
Jonathan R. Seals United States
Timothy J. Allison United States
Bo OuYang China
Yuan Feng United States
Payman Amiri United States
Deborah C. Melder United States
David L. Earnshaw
Citations per year, relative to David L. Earnshaw David L. Earnshaw (= 1×) peers Deborah C. Melder

Countries citing papers authored by David L. Earnshaw

Since Specialization
Citations

This map shows the geographic impact of David L. Earnshaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Earnshaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Earnshaw more than expected).

Fields of papers citing papers by David L. Earnshaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Earnshaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Earnshaw. The network helps show where David L. Earnshaw may publish in the future.

Co-authorship network of co-authors of David L. Earnshaw

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Earnshaw. A scholar is included among the top collaborators of David L. Earnshaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Earnshaw. David L. Earnshaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Earnshaw, David L., Ewelina Kaniuga, Małgorzata Statkiewicz, et al.. (2024). Therapeutic Responses to Two New SN-38 Derivatives in Colorectal Cancer Patient-Derived Xenografts and Respective 3DIn VitroCultures. Anticancer Research. 44(10). 4219–4224. 1 indexed citations
2.
Demin, Oleg, David L. Earnshaw, Frank Tobin, et al.. (2006). The kinetic model of the shikimate pathway as a tool to optimize enzyme assays for high‐throughput screening. Biotechnology and Bioengineering. 95(4). 560–571. 17 indexed citations
3.
Burton, George, Thomas W. Ku, Thomas J. Carr, et al.. (2005). Identification of small molecule inhibitors of the hepatitis C virus RNA-dependent RNA polymerase from a pyrrolidine combinatorial mixture. Bioorganic & Medicinal Chemistry Letters. 15(6). 1553–1556. 58 indexed citations
4.
Ranjith-Kumar, C. T., Lester L. Gutshall, Victor K. Johnston, et al.. (2003). Enzymatic activities of the GB virus-B RNA-dependent RNA polymerase. Virology. 312(2). 270–280. 20 indexed citations
5.
Lockhart, Andrew, Bill Davis, Julian C. Matthews, et al.. (2003). The peripheral benzodiazepine receptor ligand PK11195 binds with high affinity to the acute phase reactant α1-acid glycoprotein: implications for the use of the ligand as a CNS inflammatory marker. Nuclear Medicine and Biology. 30(2). 199–206. 89 indexed citations
6.
Earnshaw, David L. & Andrew J. Pope. (2001). FlashPlate Scintillation Proximity Assays for Characterization and Screening of DNA Polymerase, Primase, and Helicase Activities. SLAS DISCOVERY. 6(1). 39–46. 30 indexed citations
7.
Turconi, Sandra, Stephen Ashman, David L. Earnshaw, et al.. (2001). Real Experiences of uHTS: A Prototypic 1536-Well Fluorescence Anisotropy-Based uHTS Screen and Application of Well-Level Quality Control Procedures. SLAS DISCOVERY. 6(5). 275–290. 39 indexed citations
8.
9.
Earnshaw, David L., Keith J. M. Moore, Hakim Djaballah, et al.. (1999). Time-Resolved Fluorescence Energy Transfer DNA Helicase Assays for High Throughput Screening. SLAS DISCOVERY. 4(5). 239–248. 36 indexed citations
10.
Earnshaw, David L.. (1998). Hairpin ribozyme cleavage catalyzed by aminoglycoside antibiotics and the polyamine spermine in the absence of metal ions. Nucleic Acids Research. 26(24). 5551–5561. 107 indexed citations
11.
Marolewski, Ariane E., Derek R. Buckle, Gary Christie, et al.. (1998). CD23 (Fc∊RII) release from cell membranes is mediated by a membrane-bound metalloprotease. Biochemical Journal. 333(3). 573–579. 35 indexed citations
12.
Jenkins, Owen, David L. Earnshaw, Antonio Del Vecchio, et al.. (1996). Characterization of the helicase and ATPase activity of human papillomavirus type 6b E1 protein. Journal of General Virology. 77(8). 1805–1809. 26 indexed citations
13.
Earnshaw, David L. & Richard L. Jarvest. (1994). Characterization of the Nucleotide and DNA Coeffector Binding Sites of the Herpes Simplex Virus Type 1 (HSV-1) Encoded Helicase-Primase Complex and UL9 Origin Binding Protein. Biochemical and Biophysical Research Communications. 199(3). 1333–1340. 11 indexed citations
14.
15.
Earnshaw, David L., et al.. (1992). Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus. Antimicrobial Agents and Chemotherapy. 36(12). 2747–2757. 197 indexed citations
16.
Jarvest, Richard L., et al.. (1990). Synthesis of isotopically chiral [13C]penciclovir (BRL 39123) and its use to determine the absolute configuration of penciclovir triphosphate formed in herpes virus infected cells. Journal of the Chemical Society Chemical Communications. 555–555. 13 indexed citations
17.
Sharma, Rajesh K., Brian G. Lake, Tony Bradshaw, et al.. (1989). Differential induction of peroxisomal and microsomal fatty‐acid‐oxidising enzymes by peroxisome proliferators in rat liver and kidney. European Journal of Biochemistry. 184(1). 69–78. 84 indexed citations
18.
Earnshaw, David L., Jeremy W. Dale, Peter S. Goldfarb, & G. Gordon Gibson. (1988). Differential splicing in the 3′ non‐coding region of rat cytochrome P‐452 (P450 IVA1) mRNA. FEBS Letters. 236(2). 357–361. 38 indexed citations
19.
Earnshaw, David L., Trevor J. C. Beebee, & W.E. Gutteridge. (1987). Demonstration of RNA polymerase multiplicity in Trypanosoma brucei. Characterization and purification of α-amanitin-resistant and -sensitive enzymes. Biochemical Journal. 241(3). 649–655. 16 indexed citations
20.
Earnshaw, David L., Trevor J. C. Beebee, & W.E. Gutteridge. (1985). Unusual RNA polymerase content of Trypanosomabrucei nuclei. Biochemical and Biophysical Research Communications. 131(2). 844–848. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deborah C. Melder Breakdown of academic impact, for papers by Hongwei Yao Breakdown of academic impact, for papers by Nevena Veljković Breakdown of academic impact, for papers by Tamar Bino Breakdown of academic impact, for papers by J D Karkas Breakdown of academic impact, for papers by Jonathan R. Seals Breakdown of academic impact, for papers by Timothy J. Allison Breakdown of academic impact, for papers by Bo OuYang Breakdown of academic impact, for papers by Yuan Feng Breakdown of academic impact, for papers by Payman Amiri
Rankless by CCL
2026